TENAX THERAPEUTICS, INC. Increase (Decrease) in Notes Payable, Current
TENAX THERAPEUTICS, INC. (TENX) reported Increase (Decrease) in Notes Payable, Current of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableCurrent · last filed 2017-03-16
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for the quarter ending 2015-04-30 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for the quarter ending 2015-01-31 was $172.03K.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for the quarter ending 2014-10-31 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for the quarter ending 2014-07-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for fiscal 2016 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for fiscal 2015 was $172.03K, a 21.73% increase from fiscal 2014.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for fiscal 2014 was $141.32K, a 37.64% increase from fiscal 2013.
- TENAX THERAPEUTICS, INC. increase (decrease) in notes payable, current for fiscal 2013 was $102.67K, a 87.74% decline from fiscal 2012.
| Period end | Increase (Decrease) in Notes Payable, Current 3 month | Increase (Decrease) in Notes Payable, Current 6 month | Increase (Decrease) in Notes Payable, Current 6 month as first filed | Increase (Decrease) in Notes Payable, Current 8 month | Increase (Decrease) in Notes Payable, Current 9 month | Increase (Decrease) in Notes Payable, Current 12 month | Increase (Decrease) in Notes Payable, Current 530 month | Increase (Decrease) in Notes Payable, Current 533 month | Increase (Decrease) in Notes Payable, Current 536 month | Increase (Decrease) in Notes Payable, Current 539 month | Increase (Decrease) in Notes Payable, Current 542 month | Increase (Decrease) in Notes Payable, Current 545 month | Increase (Decrease) in Notes Payable, Current 554 month | Increase (Decrease) in Notes Payable, Current 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | |||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | |||||||||||||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $172.03K derived: sum of 2 quarters · filed 2017-03-16 | $172.03K derived: sum of 3 quarters · filed 2017-03-16 | $172.03K 10-K · filed 2017-03-16 | ||||||||||
| 2015-01-31 | $172.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $172.03K derived: sum of 2 quarters · filed 2015-03-17 | $172.03K 10-Q · filed 2015-03-17 | $172.03K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | -$4.75M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | -$4.75M derived: sum of 3 quarters · filed 2017-03-16 | -$4.78M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2014-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$4.75M derived: sum of 2 quarters · filed 2017-03-16 | -$4.78M derived: sum of 3 quarters · filed 2017-03-16 | $141.32K 10-K · filed 2017-03-16 | ||||||||||
| 2014-01-31 | -$4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$4.78M derived: sum of 2 quarters · filed 2015-03-17 | $141.32K 10-Q · filed 2015-03-17 | $141.32K derived: sum of 4 quarters · filed 2016-03-14 | $7.76M 10-Q · filed 2014-03-17 | |||||||||
| 2013-10-31 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $4.90M 10-Q · filed 2014-12-15 | $0.00 10-Q · filed 2013-12-17 | $4.90M derived: sum of 3 quarters · filed 2016-03-14 | $5.00M derived: sum of 4 quarters · filed 2016-03-14 | $7.62M 10-Q · filed 2013-12-17 | ||||||||
| 2013-07-31 | $4.92M 10-Q · filed 2014-09-15 | $4.92M derived: sum of 2 quarters · filed 2016-03-14 | $5.02M derived: sum of 3 quarters · filed 2016-03-14 | $7.62M 10-Q · filed 2013-09-17 | ||||||||||
| 2013-04-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $102.67K derived: sum of 2 quarters · filed 2016-03-14 | $102.67K 10-KT · filed 2016-03-14 | $7.62M 10-K · filed 2013-06-26 | ||||||||||
| 2013-01-31 | $102.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $102.67K 10-Q · filed 2014-03-17 | $7.62M 10-Q · filed 2013-03-18 | |||||||||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-17 | $7.52M 10-Q · filed 2012-12-14 | ||||||||||||
| 2012-07-31 | $7.52M 10-Q · filed 2012-09-19 | |||||||||||||
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $137.69K derived: sum of 2 quarters · filed 2013-06-26 | $137.69K derived: sum of 3 quarters · filed 2013-06-26 | $837.69K 10-K · filed 2013-06-26 | $7.52M 10-K · filed 2012-07-25 | |||||||||
| 2012-01-31 | $137.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | $137.69K derived: sum of 2 quarters · filed 2013-03-18 | $837.69K 10-Q · filed 2013-03-18 | $3.14M derived: sum of 4 quarters · filed 2013-03-18 | $7.52M 10-Q · filed 2012-03-15 | |||||||||
| 2011-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | $700.00K 10-Q · filed 2012-12-14 | $3.00M derived: sum of 3 quarters · filed 2012-12-14 | $5.09M derived: sum of 4 quarters · filed 2012-12-14 | $7.38M 10-Q · filed 2011-12-15 | |||||||||
| 2011-07-31 | $700.00K 10-Q · filed 2012-09-19 | $3.00M derived: sum of 2 quarters · filed 2012-09-19 | $5.09M derived: sum of 3 quarters · filed 2012-09-19 | $5.09M derived: sum of 4 quarters · filed 2012-09-19 | $7.38M 10-Q · filed 2011-09-19 | |||||||||
| 2011-04-30 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $4.39M derived: sum of 2 quarters · filed 2012-07-25 | $4.39M derived: sum of 3 quarters · filed 2012-07-25 | $4.39M 10-K · filed 2012-07-25 | ||||||||||
| 2011-01-31 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $2.09M derived: sum of 2 quarters · filed 2012-03-15 | $2.09M 10-Q · filed 2012-03-15 | |||||||||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||||||||||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |